Home/Filings/3/0001181431-11-008843
3//SEC Filing

VERSANT VENTURE CAPITAL I LP 3

Accession 0001181431-11-008843

CIK 0001162194other

Filed

Feb 8, 7:00 PM ET

Accepted

Feb 9, 9:42 PM ET

Size

43.2 KB

Accession

0001181431-11-008843

Insider Transaction Report

Form 3
Period: 2011-02-09
Holdings
  • Series E Preferred Stock

    (indirect: See footnotes)
    Exercise: $0.00Common Stock (5,185 underlying)
  • Series E Preferred Stock

    (indirect: See footnotes)
    Exercise: $0.00Common Stock (2,092 underlying)
  • Series E1 Preferred

    (indirect: See Footnotes)
    7,596
  • Series C Preferred Stock

    (indirect: See footnotes)
    Exercise: $0.00Common Stock (6,401 underlying)
  • Series D Preferred Stock

    (indirect: See footnotes)
    Exercise: $0.00Common Stock (3,715 underlying)
  • Series C Preferred Stock

    (indirect: See footnotes)
    Exercise: $0.00Common Stock (13,442 underlying)
  • Series C Preferred Stock

    (indirect: See footnotes)
    Exercise: $0.00Common Stock (5,760 underlying)
  • Series E1 Preferred

    (indirect: See Footnotes)
    346
  • Series D Preferred Stock

    (indirect: See footnotes)
    Exercise: $0.00Common Stock (1,769 underlying)
  • Series E Preferred Stock

    (indirect: See footnotes)
    Exercise: $0.00Common Stock (2,065 underlying)
  • Series B Preferred Stock

    (indirect: See footnotes)
    Exercise: $0.00Common Stock (7,297 underlying)
  • Series B Preferred Stock

    (indirect: See footnotes)
    Exercise: $0.00Common Stock (29,190 underlying)
  • Series E1 Preferred

    (indirect: See Footnotes)
    148
  • Series E Preferred Warrant (Right to Buy)

    (indirect: See footnotes)
    Exercise: $24.22Common Stock (1,417 underlying)
  • Series E1 Preferred

    (indirect: See Footnotes)
    164
  • Series B Preferred Stock

    (indirect: See footnotes)
    Exercise: $0.00Common Stock (10,425 underlying)
  • Series E Preferred Warrant (Right to Buy)

    (indirect: See footnotes)
    Exercise: $24.22Common Stock (26,181 underlying)
  • Series E Preferred Stock

    (indirect: See footnotes)
    Exercise: $0.00Common Stock (103,546 underlying)
  • Series B Preferred Stock

    (indirect: See footnotes)
    Exercise: $0.00Common Stock (474,354 underlying)
  • Series D Preferred Stock

    (indirect: See footnotes)
    Exercise: $0.00Common Stock (81,396 underlying)
  • Series E Preferred Warrant (Right to Buy)

    (indirect: See footnotes)
    Exercise: $24.22Common Stock (479 underlying)
  • Series C Preferred Stock

    (indirect: See footnotes)
    Exercise: $0.00Common Stock (294,457 underlying)
  • Series E Preferred Warrant (Right to Buy)

    (indirect: See footnotes)
    Exercise: $24.22Common Stock (544 underlying)
  • Series D Preferred Stock

    (indirect: See footnotes)
    Exercise: $0.00Common Stock (1,592 underlying)
Holdings
  • Series E Preferred Warrant (Right to Buy)

    (indirect: See footnotes)
    Exercise: $24.22Common Stock (26,181 underlying)
  • Series E Preferred Stock

    (indirect: See footnotes)
    Exercise: $0.00Common Stock (103,546 underlying)
  • Series B Preferred Stock

    (indirect: See footnotes)
    Exercise: $0.00Common Stock (10,425 underlying)
  • Series E1 Preferred

    (indirect: See Footnotes)
    164
  • Series E1 Preferred

    (indirect: See Footnotes)
    346
  • Series E1 Preferred

    (indirect: See Footnotes)
    148
  • Series E Preferred Warrant (Right to Buy)

    (indirect: See footnotes)
    Exercise: $24.22Common Stock (479 underlying)
  • Series B Preferred Stock

    (indirect: See footnotes)
    Exercise: $0.00Common Stock (7,297 underlying)
  • Series E Preferred Warrant (Right to Buy)

    (indirect: See footnotes)
    Exercise: $24.22Common Stock (1,417 underlying)
  • Series E Preferred Stock

    (indirect: See footnotes)
    Exercise: $0.00Common Stock (5,185 underlying)
  • Series E Preferred Stock

    (indirect: See footnotes)
    Exercise: $0.00Common Stock (2,092 underlying)
  • Series C Preferred Stock

    (indirect: See footnotes)
    Exercise: $0.00Common Stock (294,457 underlying)
  • Series E Preferred Stock

    (indirect: See footnotes)
    Exercise: $0.00Common Stock (2,065 underlying)
  • Series B Preferred Stock

    (indirect: See footnotes)
    Exercise: $0.00Common Stock (29,190 underlying)
  • Series E Preferred Warrant (Right to Buy)

    (indirect: See footnotes)
    Exercise: $24.22Common Stock (544 underlying)
  • Series C Preferred Stock

    (indirect: See footnotes)
    Exercise: $0.00Common Stock (5,760 underlying)
  • Series E1 Preferred

    (indirect: See Footnotes)
    7,596
  • Series D Preferred Stock

    (indirect: See footnotes)
    Exercise: $0.00Common Stock (1,769 underlying)
  • Series C Preferred Stock

    (indirect: See footnotes)
    Exercise: $0.00Common Stock (13,442 underlying)
  • Series D Preferred Stock

    (indirect: See footnotes)
    Exercise: $0.00Common Stock (3,715 underlying)
  • Series D Preferred Stock

    (indirect: See footnotes)
    Exercise: $0.00Common Stock (1,592 underlying)
  • Series B Preferred Stock

    (indirect: See footnotes)
    Exercise: $0.00Common Stock (474,354 underlying)
  • Series D Preferred Stock

    (indirect: See footnotes)
    Exercise: $0.00Common Stock (81,396 underlying)
  • Series C Preferred Stock

    (indirect: See footnotes)
    Exercise: $0.00Common Stock (6,401 underlying)
Holdings
  • Series E1 Preferred

    (indirect: See Footnotes)
    346
  • Series E1 Preferred

    (indirect: See Footnotes)
    148
  • Series E Preferred Warrant (Right to Buy)

    (indirect: See footnotes)
    Exercise: $24.22Common Stock (544 underlying)
  • Series E Preferred Warrant (Right to Buy)

    (indirect: See footnotes)
    Exercise: $24.22Common Stock (26,181 underlying)
  • Series C Preferred Stock

    (indirect: See footnotes)
    Exercise: $0.00Common Stock (294,457 underlying)
  • Series C Preferred Stock

    (indirect: See footnotes)
    Exercise: $0.00Common Stock (5,760 underlying)
  • Series E Preferred Stock

    (indirect: See footnotes)
    Exercise: $0.00Common Stock (2,065 underlying)
  • Series E1 Preferred

    (indirect: See Footnotes)
    164
  • Series C Preferred Stock

    (indirect: See footnotes)
    Exercise: $0.00Common Stock (6,401 underlying)
  • Series D Preferred Stock

    (indirect: See footnotes)
    Exercise: $0.00Common Stock (1,769 underlying)
  • Series E Preferred Stock

    (indirect: See footnotes)
    Exercise: $0.00Common Stock (5,185 underlying)
  • Series B Preferred Stock

    (indirect: See footnotes)
    Exercise: $0.00Common Stock (7,297 underlying)
  • Series E Preferred Stock

    (indirect: See footnotes)
    Exercise: $0.00Common Stock (2,092 underlying)
  • Series B Preferred Stock

    (indirect: See footnotes)
    Exercise: $0.00Common Stock (10,425 underlying)
  • Series D Preferred Stock

    (indirect: See footnotes)
    Exercise: $0.00Common Stock (1,592 underlying)
  • Series B Preferred Stock

    (indirect: See footnotes)
    Exercise: $0.00Common Stock (474,354 underlying)
  • Series E1 Preferred

    (indirect: See Footnotes)
    7,596
  • Series E Preferred Warrant (Right to Buy)

    (indirect: See footnotes)
    Exercise: $24.22Common Stock (1,417 underlying)
  • Series C Preferred Stock

    (indirect: See footnotes)
    Exercise: $0.00Common Stock (13,442 underlying)
  • Series D Preferred Stock

    (indirect: See footnotes)
    Exercise: $0.00Common Stock (3,715 underlying)
  • Series E Preferred Stock

    (indirect: See footnotes)
    Exercise: $0.00Common Stock (103,546 underlying)
  • Series D Preferred Stock

    (indirect: See footnotes)
    Exercise: $0.00Common Stock (81,396 underlying)
  • Series E Preferred Warrant (Right to Buy)

    (indirect: See footnotes)
    Exercise: $24.22Common Stock (479 underlying)
  • Series B Preferred Stock

    (indirect: See footnotes)
    Exercise: $0.00Common Stock (29,190 underlying)
Holdings
  • Series E1 Preferred

    (indirect: See Footnotes)
    7,596
  • Series E Preferred Stock

    (indirect: See footnotes)
    Exercise: $0.00Common Stock (2,065 underlying)
  • Series C Preferred Stock

    (indirect: See footnotes)
    Exercise: $0.00Common Stock (6,401 underlying)
  • Series E Preferred Stock

    (indirect: See footnotes)
    Exercise: $0.00Common Stock (5,185 underlying)
  • Series E Preferred Stock

    (indirect: See footnotes)
    Exercise: $0.00Common Stock (103,546 underlying)
  • Series E1 Preferred

    (indirect: See Footnotes)
    164
  • Series E1 Preferred

    (indirect: See Footnotes)
    346
  • Series E Preferred Warrant (Right to Buy)

    (indirect: See footnotes)
    Exercise: $24.22Common Stock (1,417 underlying)
  • Series B Preferred Stock

    (indirect: See footnotes)
    Exercise: $0.00Common Stock (474,354 underlying)
  • Series C Preferred Stock

    (indirect: See footnotes)
    Exercise: $0.00Common Stock (294,457 underlying)
  • Series E1 Preferred

    (indirect: See Footnotes)
    148
  • Series E Preferred Warrant (Right to Buy)

    (indirect: See footnotes)
    Exercise: $24.22Common Stock (479 underlying)
  • Series D Preferred Stock

    (indirect: See footnotes)
    Exercise: $0.00Common Stock (1,769 underlying)
  • Series B Preferred Stock

    (indirect: See footnotes)
    Exercise: $0.00Common Stock (29,190 underlying)
  • Series D Preferred Stock

    (indirect: See footnotes)
    Exercise: $0.00Common Stock (3,715 underlying)
  • Series D Preferred Stock

    (indirect: See footnotes)
    Exercise: $0.00Common Stock (81,396 underlying)
  • Series B Preferred Stock

    (indirect: See footnotes)
    Exercise: $0.00Common Stock (7,297 underlying)
  • Series C Preferred Stock

    (indirect: See footnotes)
    Exercise: $0.00Common Stock (13,442 underlying)
  • Series E Preferred Warrant (Right to Buy)

    (indirect: See footnotes)
    Exercise: $24.22Common Stock (544 underlying)
  • Series E Preferred Stock

    (indirect: See footnotes)
    Exercise: $0.00Common Stock (2,092 underlying)
  • Series B Preferred Stock

    (indirect: See footnotes)
    Exercise: $0.00Common Stock (10,425 underlying)
  • Series C Preferred Stock

    (indirect: See footnotes)
    Exercise: $0.00Common Stock (5,760 underlying)
  • Series D Preferred Stock

    (indirect: See footnotes)
    Exercise: $0.00Common Stock (1,592 underlying)
  • Series E Preferred Warrant (Right to Buy)

    (indirect: See footnotes)
    Exercise: $24.22Common Stock (26,181 underlying)
Footnotes (10)
  • [F1]Reflects a 1-for-1.73 reverse stock split of the Issuer's outstanding shares effected February 3, 2011.
  • [F10]Each share has no expiration date.
  • [F2]Versant Affiliates Fund 1-A, L.P., is the record holder of the securities.
  • [F3]Voting and investment power over the shares directly held by Versant Venture Capital I, L.P., Versant Affiliates Fund I-A, L.P., Versant Affiliates Fund I-B, L.P., and Versant Side Fund I, L.P. is held by Versant Ventures I, LLC, their sole General Partner. Samuel D. Colella, the reporting person is a Managing Member of Versant Ventures I, LLC but he disclaims beneficial ownership of these shares, except to the extent of his pecuniary interest therein. The individual Managing Members of Versant Ventures I, LLC are Brian G. Atwood, Samuel D. Colella, Ross A. Jaffe, William J. Link, Barbara N. Lubash, Donald B. Milder, and Rebecca B. Robertson, all of whom share voting and dispositive control. Each respective individual General Partner disclaims beneficial ownership of these shares, except to the extent of their pecuniary interest therein.
  • [F4]Versant Affiliates Fund 1-B, L.P., is the record holder of the securities.
  • [F5]Versant Side Fund 1, L.P., is the record holder of the securities.
  • [F6]Versant Venture Capital I, L.P., is the record holder of the securities.
  • [F7]Reflects the automatic conversion of each share of Series E Preferred Stock into 1.3 shares of Common Stock to occur upon the closing of the Issuer's initial public offering.
  • [F8]Expires immediately prior to the closing of the Issuer's initial public offering.
  • [F9]Reflects the automatic conversion of each share of Series B Preferred Stock, Series C Preferred Stock, Series D Preferred Stock and Series E1 Preferred Stock into one share of Common Stock to occur upon the closing of the Issuer's initial public offering. Each share has no expiration date.

Issuer

FLUIDIGM CORP

CIK 0001162194

Entity typeother
IncorporatedDE

Related Parties

1
  • filerCIK 0001268786

Filing Metadata

Form type
3
Filed
Feb 8, 7:00 PM ET
Accepted
Feb 9, 9:42 PM ET
Size
43.2 KB